# OnCo record nct05067530 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05067530/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05067530", "NCT05067530" ;
  schema:name "Cyclin dEpendent Kinase in tRiple nEGatIVe brEast canceR - a \"Window of Opportunity\" Study"@en ;
  schema:alternateName "CAREGIVER"@en ;
  schema:description "A phase 2 trial of palbociclib, paclitaxel / nab-paclitaxel and carboplatin in triple-negative breast cancer, run by Medical University of Gdansk, not yet recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05067530/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05067530> ;
  onco:status "planned" ;
  onco:tag "ctgov-ingest", "tnbc-deep-dive" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/tnbc-early/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/platinum/> ;
  onco:drugs <https://onco.cc/drugs/palbociclib/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/carboplatin/> .
